NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

The burn rate was $8M/Q, not $2M/month. That makes a difference if you are trying to run your cash down to the wire. I'm guessing that they might not have had cash to keep going beyond end of September. In which case it would not be wise to push out cash raise beyond this date. Does this raise imply no topline data till after September? Maybe, but I don't think they had $ to run much longer than end of Q3.

And it would probably not be wise to try to run cash down to 0 and still expect vendors to not demand cod.